Download full-text PDF

Source

Publication Analysis

Top Keywords

metabolic hepatic
4
hepatic muscular
4
muscular changes
4
changes zidovudine
4
zidovudine therapy
4
therapy drug-induced
4
drug-induced mitochondrial
4
mitochondrial disease?
4
metabolic
1
muscular
1

Similar Publications

A high-calorie diet and lack of exercise are the most important risk factors contributing to metabolic dysfunction-associated steatotic liver disease (MASLD) initiation and progression. The precise molecular mechanisms of mitochondrial function alteration during MASLD development remain to be fully elucidated. In this study, a total of 60 male C57BL/6J mice were maintained on a normal or amylin liver NASH (AMLN) diet for 6 or 10 weeks.

View Article and Find Full Text PDF

The Pharmacology and Toxicology of Ginkgolic Acids: Secondary Metabolites from .

Am J Chin Med

January 2025

School of Pharmacy, Nantong University, 9 Seyuan Road, Nantong 226019, P. R. China.

Ginkgolic acids (GAs) are distinctive secondary metabolites of () primarily found in its leaves and seeds, with the highest concentration located in the exotesta. GAs are classified as long-chain phenolic compounds, and exhibit structural similarities to lignoceric acid. Their structural diversity arises from variations in the length of side chains and their number of double bonds, resulting in six distinct forms within extracts (GBE).

View Article and Find Full Text PDF

Cr(VI) is widely used in industry and has high toxicity, making it one of the most common environmental pollutants. Long-term exposure to Cr(VI) can cause metabolic disorders and tissue damage. However, the effects of Cr(VI) on liver and gut microbes in fish have rarely been reported.

View Article and Find Full Text PDF

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have revolutionized the treatment of cardiometabolic diseases, extending their therapeutic applications far beyond glycemic control in type 2 diabetes (T2D) and obesity. This editorial synthesizes key milestones, from the discovery of GLP-1 to recent clinical trials highlighting the pleiotropic effects of GLP-1RAs in addressing the interconnected spectrum of cardiometabolic conditions, with a focus on cardiovascular, renal, and hepatic benefits. In addition, as GLP-1RAs continue to reshape the management of cardiometabolic disease and global public health, we discuss future challenges to better elucidate their mechanisms of cardiometabolic protection and maximize their therapeutic potential.

View Article and Find Full Text PDF

The Cross-Sectional Association Between Ultra-Processed Food Intake and Metabolic Dysfunction-Associated Steatotic Liver Disease.

Clin Nutr ESPEN

January 2025

Section of Preventive Medicine and Epidemiology, Department of Medicine, Chobanian and Avedisian School of Medicine, Boston University; Department of Health Sciences, Sargent College of Health and Rehabilitation Sciences, Boston University. Electronic address:

Background And Aims: The prevalence of Metabolic Dysfunction-Associated Steatotic Liver Disease has increased in parallel with a rise in consumption of ultra-processed foods (UPF), but little is known about their association.

Methods: We cross-sectionally examined associations of UPF with hepatic steatosis and fibrosis in 2,458 (mean age 54 years; 55.9% women) community-dwelling adults who completed vibration-controlled transient elastography and a food frequency questionnaire.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!